<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: There is good evidence in the literature that the cannabinoid system is disturbed in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In the present study, we have investigated whether CB(1) receptor immunoreactive intensity (CB(1)IR intensity) is associated with disease severity and outcome </plain></SENT>
<SENT sid="2" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: CB(1)IR was assessed in formalin-fixed, paraffin-embedded specimens collected with a consecutive intent during <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumour</z:e> surgical resection from a series of cases diagnosed with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumour</z:e> centre (n = 483) and invasive front (n = 486) CB(1)IR was scored from 0 (absent) to 3 (intense staining) and the data was analysed as a median split i.e. CB(1)IR &lt;2 and ≥2 </plain></SENT>
<SENT sid="4" pm="."><plain>In microsatellite stable, but not microsatellite instable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> (as adjudged on the basis of immunohistochemical determination of four mismatch repair proteins), there was a significant positive association of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade with the CB(1)IR intensity </plain></SENT>
<SENT sid="5" pm="."><plain>The difference between the microsatellite stable and instable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> for this association of CB(1)IR was related to the CpG island methylation status of the cases </plain></SENT>
<SENT sid="6" pm="."><plain>Cox proportional hazards regression analyses indicated a significant contribution of CB(1)IR to disease-specific survival in the microsatellite stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> when adjusting for <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> stage </plain></SENT>
<SENT sid="7" pm="."><plain>For the cases with stage II microsatellite stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e>, there was a significant effect of both <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> centre and front CB(1)IR upon disease specific survival </plain></SENT>
<SENT sid="8" pm="."><plain>The 5 year probabilities of event-free survival were: 85±5 and 66±8%; <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> interior, 86±4% and 63±8% for the CB(1)IR&lt;2 and CB(1)IR≥2 groups, respectively </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSIONS/SIGNIFICANCE: The level of CB(1) receptor expression in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> is associated with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade in a manner dependent upon the degree of CpG hypermethylation </plain></SENT>
<SENT sid="10" pm="."><plain>A high CB(1)IR is indicative of a poorer prognosis in stage II microsatellite stable <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> patients </plain></SENT>
</text></document>